2022 Annual Meeting | C12 - Tics/Tourette’s and Paroxysmal Movement Disorders

Date Saturday 04/02/22

Time 12:15 PM - 02:15 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Tamara M. Pringsheim, MD, FAAN

Topic(s) Movement Disorders

Learning Objectives Participants will get a large video-based overview of the clinical aspects of tics, functional tic-like behaviors, motor stereotypies, and primary (genetic) and secondary forms of paroxysmal movement disorders, particularly paroxysmal dyskinesia, episodic ataxia, benign developmental movement disorders, and paroxysmal functional movement disorders. Participants should learn to recognize and identify these movement disorders and develop an approach to diagnosis and treatment.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
12:15 PM - 12:20 PM PDT	Introduction	Introduction Tamara M. Pringsheim, MD, FAAN
12:15 PM - 02:15 PM PDT	Speaker	walk in slides Tamara M. Pringsheim, MD, FAAN
12:20 PM - 01:10 PM PDT	Speaker	Tourette Syndrome, Functional Tic-Like Behaviors, and Stereotypies Tamara M. Pringsheim, MD, FAAN
01:10 PM - 02:00 PM PDT	Speaker	Paroxysmal Movement Disorders Emmanuel Roze, MD, PhD
02:00 PM - 02:15 PM PDT	Q&A	Questions and Answers Tamara M. Pringsheim, MD, FAAN, Emmanuel Roze, MD, PhD

Faculty Disclosures
Tamara M. Pringsheim, MD, FAAN	The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Emmanuel Roze, MD, PhD	Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation.